ProShares UltraShort Health Care (NYSEARCA:RXD) Sees Significant Growth in Short Interest

ProShares UltraShort Health Care (NYSEARCA:RXD) saw a significant growth in short interest in July. As of July 31st, there was short interest totaling 5,647 shares, a growth of 154.3% from the July 15th total of 2,221 shares. Currently, 2.8% of the shares of the stock are sold short. Based on an average daily trading volume, of 11,013 shares, the short-interest ratio is currently 0.5 days.

ProShares UltraShort Health Care Price Performance

Shares of NYSEARCA:RXD traded up $0.22 on Friday, reaching $15.32. 2,010 shares of the company traded hands, compared to its average volume of 7,179. The company’s 50 day moving average is $16.88 and its 200-day moving average is $18.52. ProShares UltraShort Health Care has a fifty-two week low of $14.98 and a fifty-two week high of $25.54.

Institutional Investors Weigh In On ProShares UltraShort Health Care

A hedge fund recently bought a new position in ProShares UltraShort Health Care stock. IMC Chicago LLC purchased a new stake in ProShares UltraShort Health Care (NYSEARCA:RXD) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 20,581 shares of the company’s stock, valued at approximately $209,000. IMC Chicago LLC owned 4.29% of ProShares UltraShort Health Care as of its most recent SEC filing.

ProShares UltraShort Health Care Company Profile

ProShares UltraShort Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the inverse (opposite) of the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, to investments that, in combination, have economic characteristics that are inverse to those of the Index. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments.